F-star Therapeutics's total assets for Q were $83.72M, a decrease of -16.82% from the previous quarter. DE:S4BA total liabilities were $83.72M for the fiscal quarter, a 188.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.